Both the first and second quarters of 2018 saw an increase in investments, totaling nearly $778 million and $786 million respectively. The third and fourth quarters were slightly lower, with medtech companies raising $738 million in Q3 and nearly $641 million in Q4.
There were 218 deals in 2018, a slight decrease from the 229 deals involving medical device companies in 2017. There was 55 deals in Q1, 68 in Q2, 48 in Q3 and 47 in Q4.
The companies that are raising VC cash are doing everything from cardiac arrhythmia detection to proton therapy for cancer patients.
Read on to discover the top medtech venture capital raises of 2018.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.